Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Thoracic abdominal aortic stent graft used to treat  Type B aortic dissections (TBAD). The STS and SVS released new reporting standards for TBAD.
News | Endovascular Aortic Repair | January 31, 2020
January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting...
Abbott Tendyne TMVR, TMVI system received European CE mark clearance in January 2020. The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system uses an anchor attached to the apex of the heart with a whether line attached to the valve. This helps to keep the valve anchored in the mitral annulus and prevent embolization. This anchor system was used because, unlike the aortic valve, the mitral valve has a very thin landing zone to secure the valve. Prevents LVOT obstruction.

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system uses an anchor attached to the apex of the heart with a whether line attached to the valve. This helps to keep the valve anchored in the mitral annulus and prevent embolization. This anchor system was used because, unlike the aortic valve, the mitral valve has a very thin landing zone to secure the valve. The design also eliminated any hardware hanging or folding into the left ventricle, which could cause left ventricular outflow track (LVOT) obstruction, which can prevent blood flow through the aortic valve and to the rest of the body.

Feature | Heart Valve Technology | January 30, 2020
January 30, 2020 — The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received European CE mark...
Videos | Heart Valve Technology | January 28, 2020
Interview with Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center,...
Videos | Cath Lab | January 24, 2020
Interview with Carey Kimmelstiel, M.D., FACP, FACC, director, cardiac catheterization laboratory, director,...
Videos | Hemodynamic Support Devices | January 24, 2020
Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of...
This is an example of artificial intelligence automation for cardiac MRI using an AI app from TeraRecon's Envoy AI marketplace. The GE MRI image has bee countoured, anatomy labeled and all quantification automated by the AI, greatly reducing post-processing time. See this and other new AI imaging technologies from the 2019 RSNA meeting.

This is an example of artificial intelligence automation for cardiac MRI using an AI app from TeraRecon's Envoy AI marketplace. The GE MRI image has been countoured, anatomy labeled and all quantification automated by the AI, greatly reducing post-processing time. See this and other new AI imaging technologies from the 2019 RSNA meeting.

Blog | January 24, 2020
The key question I am always asked at cardiology conferences is what are the trends and interesting new technologies I...
The BioVentrix Revivent TC transcatheter device anchors that help cinch the heart mucsle using a transcatheter procedure to treat left ventricular remodeling associated with heart failure following a heart attack. BioVentrix Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, announced the extension of its European CE mark approval for the Revivent TC Transcatheter Ventricular Enhancement System for heart failure to May 2024.

The BioVentrix Revivent TC transcatheter device anchors that help cinch the heart mucsle using a transcatheter procedure to treat left ventricular remodeling associated with heart failure following a heart attack.

News | January 22, 2020
January 22, 2020 – BioVentrix Inc., developer of the first transcatheter device for left ventricular remodeling after a...
Videos | Robotic Systems | January 20, 2020
This video shows the first robotic percutaneous coronary interventions (PCI) performed in Germany with the Robocath R-...
Professor Michael Haude, director of Medical Clinic I at Rheinland Klinikum Neuss Lukaskrankenhaus, performing a PCI using the Robocath R-One robotic catheter guidance system. 

Professor Michael Haude, director of Medical Clinic I at Rheinland Klinikum Neuss Lukaskrankenhaus, performing a PCI using the Robocath R-One robotic catheter guidance system. 

News | Robotic Systems | January 21, 2020
January 21, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the...
Tufts Medical Center cath lab team performing an ECMO cannulation for hemodynamic support.
360 Photos | 360 View Photos | January 21, 2020
A venous-venous (VV) extracorporeal membrane oxygenation (ECMO) implantation procedure in a cath lab at Tufts Medical...
The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert consensus statement for the “SCAI Best Practices for Transradial Angiography and Intervention.”
News | Radial Access | January 15, 2020
January 15, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert...
Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit.

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit. 

News | Cardiac Rehabilitation | January 15, 2020
January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart...
This is the latest version of the MitraClip, the G4, which allows each side of the clip to be opened and closed independently to offer more flexibility when capturing the valve leaflets. The device is being used in the REPAIR MR clinical trial.

This is the latest version of the MitraClip, the G4, which allows each side of the clip to be opened and closed independently to offer more flexibility when capturing the valve leaflets. The device is being used in the REPAIR MR clinical trial. 

News | Heart Valve Technology | January 13, 2020
January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the...
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
Videos | Hemodynamic Support Devices | January 09, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa...